Amedisys Reports Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Amedisys (AMED) Tops Q2 EPS by 12c
July 26, 2017 5:02 PM EDTAmedisys (NASDAQ: AMED) reported Q2 EPS of $0.62, $0.12 better than the analyst estimate of $0.50. Revenue for the quarter came in at $378.8 million versus the consensus estimate of $380.7 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
... More